Best Time to Take Tesamorelin: Morning vs. Night, Dosing and Injection Timing

Tesamorelin generates a lot of confident advice online: take it only before bed, do not eat for two or three hours around the injection, split the dose between morning and night, or draw a certain number of “units” into an insulin syringe. Some of those recommendations have a physiologic rationale or may reflect an individual clinic's protocol. They are not all universal rules.

This guide separates what people commonly say from what the current prescribing information and available evidence actually establish. That distinction matters because tesamorelin formulations, concentrations and patient goals are not interchangeable.

Written by the NovaGenix Editorial Team · Medically reviewed by Timothy Mackey, D.O., Medical Director
Florida License OS9185 · Last medically reviewed: October 5, 2026

Learn about physician-guided tesamorelin therapy at NovaGenix

Should tesamorelin be taken in the morning or at night?

The FDA-approved products EGRIFTA WR and EGRIFTA SV are dosed once daily. Their prescribing information specifies the dose, formulation, reconstitution and injection site, but it does not require a specific morning or nighttime administration window.

That means the most accurate answer is not “morning is best” or “bedtime is best.” The appropriate timing depends on the formulation, the prescriber's instructions, the patient's routine and the clinical reason the medication is being used.

Why do people say tesamorelin should be taken before bed?

Sleep and growth hormone physiology are genuinely related. Reviews of human GH secretion show that a major secretory episode often follows sleep onset and is associated with slow-wave sleep. That helps explain the popularity of nighttime protocols, but it does not by itself answer whether a specific tesamorelin patient will obtain a better clinical result at 10 p.m. than at 8 a.m.

Does tesamorelin have to be taken on an empty stomach?

If your prescription includes specific instructions about meals, follow those instructions. If it does not, do not invent a fasting schedule based solely on social media, a peptide forum or a protocol written for a different formulation.

Can you take 1 mg of tesamorelin in the morning and 1 mg at night?

This is an important question because patients sometimes assume that splitting a daily amount will provide more even exposure or better mimic natural hormone pulses.

For FDA-approved EGRIFTA products, the labeled regimens are once daily. The current EGRIFTA WR label specifies 1.28 mg once daily, while EGRIFTA SV specifies 1.4 mg once daily. Neither label establishes a morning-plus-evening split as superior.

The fact that a medication has a particular half-life also does not automatically mean that dividing it into two injections improves outcomes. Dosing decisions should be based on the exact formulation and the treatment plan prescribed for the patient.

Why tesamorelin dosage depends on the formulation

Tesamorelin is a good example of why online dosing shortcuts can be misleading. FDA-approved formulations have different strengths, reconstitution instructions, storage requirements and injection volumes.

That is why “How many milligrams of tesamorelin should I take?” is not a question that should be answered without knowing the exact product and the patient's prescription.

How many units of tesamorelin should you draw into an insulin syringe?

• mg describes the amount of medication.
• mL describes liquid volume.
• Insulin-syringe units are another way of marking volume.
• You cannot safely convert mg to syringe units without knowing the concentration in mg/mL.

A generic online chart can therefore be correct for one preparation and wrong for another. This is exactly why tesamorelin instructions should remain formulation-specific.

Where should tesamorelin be injected?

FDA-approved EGRIFTA WR and EGRIFTA SV are administered by subcutaneous injection into the abdomen. The prescribing information directs patients to rotate injection sites and avoid scar tissue, bruises and the navel.

Patients should receive instruction on how to prepare and inject their exact product before self-administration. Reconstitution instructions also differ between formulations, which is another reason not to use a universal online protocol.

For a broader overview of dosage, indications, monitoring and treatment considerations, visit the NovaGenix tesamorelin therapy guide.

Does it matter if you take tesamorelin at the same time every day?

Consistency is generally more useful than chasing a theoretically perfect clock time. A repeatable schedule reduces missed doses and makes it easier for the clinician and patient to evaluate response and tolerability.

If your physician has chosen a morning or evening schedule for a specific reason, follow that plan. If timing needs to change because of travel, work shifts or another medication, ask whether the schedule should be adjusted rather than improvising.

What should you do if you miss a tesamorelin dose?

Do not automatically double the next injection. Missed-dose instructions can depend on the exact product and patient circumstances. Review the medication instructions supplied with your prescription or contact the prescribing clinic or pharmacy if you are unsure what to do.

The same principle applies if medication was mixed incorrectly, stored improperly, appears discolored or contains particles. Do not guess.

What should be monitored during tesamorelin treatment?

Tesamorelin affects the growth hormone–IGF-1 pathway, so treatment is more than choosing an injection time. Appropriate follow-up may include clinical response, IGF-1 and glucose-related monitoring depending on the patient's history and indication.

The FDA labeling includes important warnings involving elevated IGF-1, glucose intolerance or diabetes, fluid retention, hypersensitivity and injection-site reactions. Tesamorelin is also contraindicated in pregnancy and in certain patients with active malignancy or disruption of the hypothalamic-pituitary axis.

Patients with relevant cancer history, glucose abnormalities, pituitary disease or other significant medical conditions require individualized evaluation before treatment is considered.

Morning vs. night: the NovaGenix approach

NovaGenix does not reduce tesamorelin treatment to “take it at bedtime” or “never eat near the injection.” Timing matters less than getting the fundamentals right: the correct product, the correct dose, proper preparation, appropriate monitoring and a plan that the patient can follow consistently.

For some patients, a physician may prefer nighttime administration because of growth hormone physiology. For another patient, a different schedule may make more sense. The important distinction is that a clinical preference should not be presented as though it were a universal FDA requirement.

This is also why NovaGenix does not recommend copying another patient's reconstitution instructions, insulin-syringe units or dose-splitting schedule.

Frequently asked questions

What time should I inject tesamorelin?

FDA-approved EGRIFTA products are administered once daily, but the labeling does not establish a required morning or nighttime dosing window. Follow the schedule provided by your prescriber.

Can I take tesamorelin in the morning?

The approved labeling does not prohibit morning administration. Whether morning is appropriate for you depends on the treatment plan provided by your clinician.

Is tesamorelin better before bed?

There is a physiologic reason some clinicians prefer bedtime because growth hormone secretion is strongly associated with sleep. Current prescribing information, however, does not establish bedtime as clinically superior for every patient.

Should tesamorelin be taken fasted?

The current EGRIFTA WR and EGRIFTA SV labeling does not require a universal two- or three-hour fasting window. Follow any meal-timing instructions given specifically with your treatment plan.

Can tesamorelin be split into two daily doses?

FDA-approved EGRIFTA regimens are once daily. Do not divide or change a prescribed dose without explicit guidance from your prescriber.

Where do you inject tesamorelin?

Approved EGRIFTA products are injected subcutaneously into the abdomen. Injection sites should be rotated, and the navel, scars and bruised areas should be avoided.

How many insulin-syringe units equal 1 mg of tesamorelin?

There is no universal answer. Syringe units measure volume, and the correct volume depends on the concentration of the prepared medication. Use the instructions for your exact prescription.

Are EGRIFTA WR and EGRIFTA SV the same dose?

No. EGRIFTA WR is labeled at 1.28 mg once daily and EGRIFTA SV at 1.4 mg once daily. Their strengths, preparation instructions and injection volumes differ, and the products are not interchangeable.

Does tesamorelin need to be taken at exactly the same time every day?

A consistent routine can help reduce missed doses, but patients should follow their prescriber's specific instructions rather than changing timing based on an online protocol.

NovaGenix Health & Wellness | 609 N Hepburn Ave Ste 106, Jupiter, FL 33458 | Call or text 561-277-8260

Related NovaGenix guides

• Tesamorelin vs. HGH: How Are They Different?
• Tesamorelin for Women: Benefits, Safety & FDA Status
• NovaGenix Peptide Therapy Guide

Medical references

FDA: EGRIFTA WR prescribing information

DailyMed: EGRIFTA SV prescribing information

PubMed: Physiology of growth hormone secretion during sleep

NCBI Bookshelf: Normal Physiology of Growth Hormone in Normal Adults

Medical disclaimer: This article is for general educational purposes and does not provide medical advice, diagnosis or an individualized treatment recommendation. Tesamorelin has a specific FDA-approved indication, and treatment decisions require evaluation by a qualified healthcare professional.